Brussels has ended a customs exemption for low-value imports from China while agreeing with Beijing to monitor trade flows ...
VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for ...
The new training series offers a pathway for IT professionals to strengthen their cyber security skills and better understand ...